PRASHANT PUSPANTHAN

Prashant Puspanathan

Co-founder at Enosis Therapeutics

Dr. Prash P is a consultant psychiatrist, psychedelic therapist and entrepreneur at the forefront of psychedelic-assisted psychotherapy.

Alongside his private practice, he works as a psychedelic therapist and researcher at the Clinical Psychedelic Lab at Monash University. As a founding member of Psychedelic Institute Australia, he is a vocal advocate for evidence-based, accessible psychedelic care, and has contributed to leading journals including The Lancet and the Australian & New Zealand Journal of Psychiatry, where he promotes the integration of novel therapies into mainstream psychiatry.

He is the co-founder of Enosis Therapeutics, a company pioneering the fusion of immersive technology and psychedelic therapy. Enosis holds an Australian Innovation Patent for its groundbreaking clinical protocol that integrates Virtual Reality with psychedelic-assisted psychotherapy—an approach that has defined a new frontier in treatment, known as Spatial Therapeutics (STx).

Outside the clinical space, Dr. Prash is also the founder of Caleb & Brown, Australia’s largest personalised cryptocurrency brokerage. The firm was awarded Fintech Startup of the Year in 2018 for bridging traditional financial services with the emerging digital asset economy. In 2018, he was named Young Executive of the Year by the Australian Indian Executive Council for his visionary leadership across medicine and technology.